Labcorp’s Post

I´m happy to share with you this very usefull "Handbook of Assays for Developing Targeted Therapeutics" which includes example experiments used to develop existing therapeutics. These examples show you how others have used assays in a creative way and may spark some new ideas. The case studies cover: - Target identification - Gene therapy - Dose response - Phenotypic effect assessment - Delivery and in vivo characterization Keep a steady flow of new ideas with the “Handbook of Assays for Developing Targeted Therapeutics.” https://lnkd.in/dPFT8Xt2

Don't miss the new Drug Discovery World newsletter, with all the latest in cancer research and gene therapy news, as well as analysis of the RNA landscape and AI's role in drug repurposing. https://lnkd.in/e3Q6ZNUa #drugdiscovery #drugdevelopment #pharma #biotech #newsletter

#Gene and #cell-based therapies have the potential to provide targeted and personalized treatments, according to Charité - Universitätsmedizin Berlin and Bayer. They are a beacon of hope for people for whom conventional therapies have failed or for whom there is no treatment so far. With Charité and Bayer, two partners for major medical progress are coming together who will establish a new center for gene and cell therapy in #Berlin, which is to be established in 2025. More information in first comment #healthforall #teambayer

Regenerative medicine is not a distant reality—it's a transformative force that's shaping the world of medicinal therapeutics today. At Two Labs, we’ve proudly guided manufacturers from the earliest stages of pre-clinical development through to the life-changing patient outcomes that follow. If you missed our latest insights on the current state of the cell and gene therapy pipeline, we've made it easy to catch up. Check out our comprehensive webinar recap that charts the progress and previews the breakthroughs on the horizon. Start with the blog here and access the full webinar within for a full recap of where the pipeline stands. https://bit.ly/48wftyD

Complement drug discovery is booming, and Svar is at the forefront with functional cell-based and immunoassay, and biomarker assays. Join us for the ultimate hub of scientific advancements, where we'll talk about the role of complement in AAV gene therapy, along with new poster for our cell-based anaphylatoxin assessment. Don't forget to connect with our scientific experts to discover customizable Complement System solutions for your project! If you're too busy during the event, you can always contact us here: https://hubs.ly/Q02BRTmB0 #ComplementSystem #ComplementBiology #DrugDevelopment #ComplementingLifeScience #AnswesInLifeScience

新增一批生物药和CGT研发职位（Antibody Discovery，Biology，immune-oncology， cell therapy process，cell therapy Discovery，AAV gene therapy Discovery，DMPK）https://lnkd.in/gVFt2Hj5

We are very pleased to announce that our CEO, Eric Halioua will be on stage today in a panel at the Cell Therapy Manufacturing & Gene Therapy Congress organized by Informa in Dublin, Ireland. At 11:30 Eric, accompanied by Imen Mestiri, Thibault Jonckheere, and George Frodsham, will address Partnership Challenges in Cell & Gene Therapy as the market conditions change. What will be discussed? - Exploring the impacts of market conditions on CGT partnerships. - Understanding the evolving landscape of collaboration between small innovators and large biotechs. - Evaluating current partnership strategies and how they can be improved. https://lnkd.in/eeWBzXk

If you're at the American Society of Gene & Cell Therapy meeting, stop by the Donaldson booth and learn about innovative technologies in #scaleup and #purification. Also, say hello to my teammates David Moccia, Matt Kremer, Corey Jacklin and Floriane Cohen for me! They call tell you all about our Scale-X platform and how it can help reduce cost and maximize efficiency in suspension and adherent workflows! #biorectors #bioprocess

📆Day one at the 𝟑𝐫𝐝 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐏𝐨𝐭𝐞𝐧𝐜𝐲 𝐀𝐬𝐬𝐚𝐲 𝐒𝐮𝐦𝐦𝐢𝐭 in Boston and the Cellply team, Massimo Bocchi and Marco Fadda, are joining the many discussions about the challenges of potency assay development for these therapeutics. They are joining the many analytical, QC, and regulatory experts who are sharing insights into the real-world issue and assessing the impact of the FDA’s draft guidance “Potency assurance for cellular and gene therapy products”.   With VivaCyte now available commercially, there is a 𝐧𝐞𝐰 𝐩𝐫𝐚𝐜𝐭𝐢𝐜𝐚𝐥 𝐨𝐩𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐝𝐞𝐞𝐩 𝐜𝐡𝐚𝐫𝐚𝐜𝐭𝐞𝐫𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞𝐬𝐞 𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 that offers novel insights to enhance understanding of these vital cell therapy products. 📍𝐁𝐎𝐎𝐓𝐇 #𝟒 #CellCharacterization #PotencyAssay #CellTherapy

Are we ready to deliver therapies to patients quickly and efficiently? How can we address challenges of new modalities' needs? Listen my podcast where I share my view on how to pave the way for an industry alignment to deliver best practices in clinical and commercial outbound supply chains. #cellandgenetherapy #cgt #advancedtherapies #supplychainmanagement #sartorius